Diseases & Conditions

Summer is coming to an end, but here at Pfizer, the work doesn’t stop when the seasons change.

Eight years ago, few people had heard of transthyretin amyloid cardiomyopathy (ATTR-CM), and it was rarely diagnosed in cardiology practice.1,2 Today, it is a treatable condition that cardiologists and heart failure specialists actively screen for, with dedicated clinics, imaging pathways, and a gro

When living with a lifelong condition like hemophilia, decisions about care and treatment are rarely simple.

Even amidst the cookouts, fireworks, and vacations, Pfizer remains hard at work all summer long, and July was no different.Last month, we held important conversations around living with alopecia areata, shared the story of a Pfizer colleague and cancer survivor, and reflected on the changes in scien

For millions of people who menstruate, migraine attacks don’t always strike at random. For many, they’re more likely to occur in and around the days of the menstrual period, driven in part by the hormonal shifts of the cycle.

For some people, migraine attacks aren’t random. Instead, they follow predictable hormonal rhythms that unfold over time.

Summer’s approaching fast, but here at Pfizer the work doesn’t stop.

For many people living with transthyretin amyloid cardiomyopathy (ATTR‑CM) – a rare and underdiagnosed cause of heart failure – receiving an accurate diagnosis can be a long and uncertain journey.1,2 Symptoms often resemble more common heart conditions, and early clues are easy to miss.1 But, new re

Lyme disease is the most common vector-borne illness in the United States.1 Caused by the bacteria Borrelia burgdorferi sensu lato and spread through infected tick bites, it affects an estimated 476,000 Americans each year.1,3Yet the burden of Lyme disease, particularly the experience of a timely di

Cachexia, a complex wasting syndrome, impacts an estimated 9 million people worldwide.[i] In people living with cancer, cachexia can diminish the tolerance of therapies and is linked to reduced survival rates.